
Shareholding13 Jul 2026, 01:10 pm
Panacea Biotec: Promoter Group Acquires 2 Lakh Shares via Gift
AI Summary
Panacea Biotec Limited has filed a disclosure regarding an inter-se transfer of shares within the promoter group. Rajesh Jain (HUF) acquired 2,00,000 equity shares of the company from Dr. Rajesh Jain through a gift. This acquisition was made under Regulation 10(1)(a)(ii) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, for which an exemption report was submitted to SEBI on July 8, 2026. The transaction resulted in Rajesh Jain (HUF)'s shareholding increasing to 0.09% and Dr. Rajesh Jain's shareholding decreasing to 13.48%. The filing confirms compliance with relevant SEBI regulations.
Key Highlights
- Rajesh Jain (HUF) acquired 2,00,000 shares via gift from Dr. Rajesh Jain.
- Acquisition falls under SEBI SAST Regulations, Regulation 10(1)(a)(ii).
- Promoter group shareholding adjusted post-transaction.
- Exemption report filed with SEBI on July 8, 2026.
- Transaction is an inter-se transfer within the promoter group.
Price Impact
More from PANACEABIO